Research Award for Dr. Philip Bucher
Congratulations to Dr. Philip Bucher on receiving the 2026 Dr. Maresch-Klingelhöffer Research Award from the Frankfurter Stiftung für krebskranke Kinder!
The award was presented during a festive ceremony in Frankfurt on November 5, 2026, recognizing Philip Bucher's contributions to advancing next-generation CAR T-cell therapies.
🔬 As a researcher at University Hospital Tübingen and member of the iFIT Cluster of Excellence, Dr. Bucher works within the research groups led by iFIT members Prof. Judith Feucht and Jun.-Prof. Josef Leibold. His research focuses on innovative genetic engineering approaches to improve the effectiveness and long-term persistence of CAR T cells, aiming to expand their therapeutic potential against difficult-to-treat cancers, including solid tumours.
During the award ceremony, Dr. Bucher presented insights into his research, highlighting the potential of innovative CAR T-cell therapies for the future of cancer treatment. The laudatory speech was delivered by Prof. Dirk Heckl, Head of the Institute for Experimental Pediatric Hematology and Oncology (EPHO), Goethe University of Frankfurt.
The Dr. Maresch-Klingelhöffer Research Award is presented by the Frankfurter Stiftung für krebskranke Kinder, a foundation dedicated to supporting innovative cancer research and improving treatment perspectives for children with cancer.
✨ This marks another major recognition of Philip Bucher's scientific achievements in 2026, following his earlier receipt of the DAG-HSZT Research Award.
👏 Congratulations to Philip and the entire research team on this well-deserved achievement!
Photo: Rainer Rüffer